First-in-human Study of UX016 in GNEM
Clinical trial NCT07511556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07511556
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.